Form 4 for PRME Prime Medicine, Inc.
Accepted 2024-06-07 00:00:00 ET · period of report 2024-06-05 · accession 0001894562-24-000026 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2024-06-07 | 2024-06-05 | PRME | Gottesdiener Keith Michael | See Remarks, Dir | G - Gift | $0.00 | +250.0K | 277.2K | +920% | $0 |
| 2024-06-07 | 2024-06-05 | PRME | Gottesdiener Keith Michael | See Remarks, Dir | G - Gift | $0.00 | -250.0K | 2.31M | -10% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-05 | G | A | 250,000 | $0.00 | 277,166 | I | — | — | (F1) On June 5, 2024, for bona fide estate planning purposes, the Reporting Person transferred 250,000 shares of Issuer common stock to his spouse for no consideration. |
| 2 | Common | Common Stock | 2024-06-05 | G | D | 250,000 | $0.00 | 2,310,837 | D By Spouse | — | — | (F1) On June 5, 2024, for bona fide estate planning purposes, the Reporting Person transferred 250,000 shares of Issuer common stock to his spouse for no consideration. |